Land: Australië
Taal: Engels
Bron: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CANINE PARVOVIRUS (INACTIVATED); THIOMERSAL
ZOETIS AUSTRALIA PTY LTD
canine parvovirus
PARENTERAL LIQUID/SOLUTION/SUSPENSION
CANINE PARVOVIRUS (INACTIVATED) VACCINE-VIRAL Active 0.0 U; THIOMERSAL MERCURY Other 0.1 mg/ml
10mL Vial; 1mL Vial; 20 x 1mL syringes; 20 x 1mL Vials; 25 x 1mL Syringes; 25 x 1mL Vials
VM - Veterinary Medicine
ZOETIS AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
IMMUNOTHERAPY
CANINE PARVOVIRUS | PARVOVIRUS
Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [CANINE PARVOVIRUS]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [CANINE PARVOVIRUS]; For the immunisation of dogs against canine parvovirus.This product should not be use in dogs when they are: incubating an infectious disease; seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or under treatment with immunosuppressive drugs.
Registered
2023-07-01
Product Name: APVMA Approval No: PARVAC VACCINE 51777 / 129907 Label Name: PARVAC VACCINE Signal Headings: FOR ANIMAL TREATMENT ONLY Constituent Statements: Canine Parvovirus (inactivated) ≥ 10^5.0 TCID50/mL 0.1 mg/mL Thiomersal as preservative. Claims: For the immunisation of dogs against canine parvovirus. Net Contents: 20 x 1mL Vials 20 x 1mL Syringes 10mL Vial 1mL Vial 25 x 1mL Vials 25 x 1mL Syringes Directions for Use: Restraints: Contraindications: This product should not be used in dogs when they are: 1. incubating an infectious disease; 2. seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or 3. under treatment with immunosuppressive drugs. Precautions: Side Effects: As Parvac Vaccine is an inactivated vaccine, untoward systemic effects are very rare and the vaccine may be used in pregnant bitches. However, the adjuvant will cause a temporary local reaction at the site of injection, though this is seldom visible. Careful palpation may reveal a small fibrous nodule at the site of vaccination in some dogs about one week post- vaccination. This nodule will regress, becoming impalpable within two to six weeks. In a very few small, smooth-coated dogs, such a nodule may be visible for a limited period. RLP APPROVED Dosage and Administration: Parvac Vaccine is an adjuvanted vaccine; there may be settling of the adjuvant after storage but the material is easily resuspended by inversion of the syringe or bottle. Use all product within 12 hours of opening. The vaccine is injected subcutaneously. A 1 mL dose is recommended for dogs of all ages. Gentle massage at the site of injection will help to disperse the vaccine. Shake gently before use. REMOVAL OF THE NEEDLE COVER Do not attempt to screw off needle cover Ease off by twisting syringe to and fro gently General Directions: Parvac Vaccine is an inactivated vaccine prepared from ≥ 10^5.0 TCID50/mL canine parvovirus grown aseptically in a continuous cell line. An aluminium salt is included to enhance the response to vacc Lees het volledige document
PRODUCT NAME: PARVAC® VACCINE PAGE: 1 OF 6 THIS VERSION ISSUED: 19 FEBRUARY 2015 SAFETY DATA SHEET Issued by: Zoetis Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA SECTION 1 - IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND SUPPLIER ZOETIS AUSTRALIA PTY LTD ABN 94 156 476 425 Level 6, 5 Rider Blvd Rhodes NSW 2138 AUSTRALIA Tel: 1800 814 883 Fax: (02) 8876 0444 Email: australia.animalhealth@zoetis.com PRODUCT IDENTIFIER: PARVAC® VACCINE OTHER NAMES: None. APVMA APPROVAL NO: 51777 CHEMICAL FAMILY: Inactivated Canine Parvovirus Vaccine in an aqueous medium. RECOMMENDED USE: For the control of parvovirus in dogs by injection. RESTRICTIONS ON USE For veterinary use only. EMERGENCY PHONE: 1800 814 883 (ALL HOURS) SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMDG/IMSBC criteria. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S23, S25, S36. Do not breathe mists. Avoid contact with eyes. Wear suitable protective clothing. ADG CLASSIFICATION: None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMDG/IMSBC criteria. GHS LABEL ELEMENTS: NONE SIGNAL WORD: NONE – NOT HAZARDOUS. GHS CLASSIFICATION: NOT HAZARDOUS. PREVENTION P102: Keep out of reach of children. P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required. RESPONSE P353: Rinse skin or shower with water. P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P370+P378: Not combustible. Use extinguishing media suited to burning materials. STORAGE P410: Protect from sunlight. P411: Store at temperatures preferably between 2 and 8°C, but do not freeze. P403+P233: Store in a well-ventilated place. Keep container tightly closed. DISPOSAL P501: Dispose of small quantities and empty containers by wrapping with pa Lees het volledige document